HeartBeam, Inc. (BEAT) vs Edesa Biotech, Inc. (EDSA)
A side-by-side comparison of HeartBeam, Inc. and Edesa Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BEAT
HeartBeam, Inc.
$0.59HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
EDSA
Edesa Biotech, Inc.
$3.91HealthcareDelayed quote: Oct 6, 2026, 12:37 PM EDT
Total return — BEAT vs EDSA
growth of $100 · dividends reinvested · last 5yBEAT -86.1% (-32.6%/yr)EDSA -92.1% (-39.8%/yr)BEAT compounded faster over this window
BEAT EDSA
BEAT vs EDSA: by the numbers
- •EDSA is the larger company ($38M vs $33M market cap).
Metrics side by side
Valuation
| Metric | BEAT | EDSA |
|---|---|---|
| P/B ratio | 3.99 | 94.41 |
Profitability
| Metric | BEAT | EDSA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -248.21% | -160.05% |
| ROIC | -249.58% | -166.02% |
Growth (annualized)
| Metric | BEAT | EDSA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -39.88% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.